Catalyst Wire Dossier Catalyst Wire Dossier

Oral ferric iron formulation

· Shield Therapeutics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Oral ferric iron formulation, covering 2017-10-27 to 2017-10-27. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Crohn's Disease (AEGIS-2) [Phase 3]

See pricing